Corvus Pharmaceuticals
CRVS
$1.58
Share price
8.97%
Change (1 day)
42.34%
Change (1 year)
Categories
Corvus Pharmaceuticals (CRVS) - P/B ratio
P/B ratio as of April 2024 : 2.00
According to Corvus Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 2.00.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Corvus Pharmaceuticals - P/B ratio (from 2016 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.23 | 216.39% |
| 2022-12-31 | 0.7052 | -38.92% |
| 2021-12-31 | 1.15 | -16.62% |
| 2020-12-31 | 1.38 | -35.25% |
| 2019-12-31 | 2.14 | 119.24% |
| 2018-12-31 | 0.9754 | -62.04% |
| 2017-12-31 | 2.57 | 14.11% |
| 2016-12-31 | 2.25 | |
| 2015-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.48 | 23.63% | 🇺🇸 USA |